Captrust Financial Advisors Xencor Inc Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$19.74 - $29.01 $2,289 - $3,365	116 Added 17.96%	762 $21,000
Q1 2022 May 16, 2022	BUY	$26.68 - $41.63 $4,002 - $6,244	150 Added 30.24%	646 $17,000
Q3 2021 Nov 16, 2021	SELL	$30.65 - $35.68 $7,447 - $8,670	-243 Reduced 32.88%	496 $16,000
Q2 2021 Aug 16, 2021	SELL	$34.33 - $44.68 $5,458 - $7,104	-159 Reduced 17.71%	739 $25,000
Q1 2021 May 17, 2021	BUY	$40.81 - $53.88 $32,158 - $42,457	788 Added 716.36%	898 $39,000
Q4 2020 Feb 16, 2021	BUY	$36.63 - $47.63 $4,029 - $5,239	110 New	110 $5,000

216

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.23B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.